Copyright
©The Author(s) 2021.
World J Cardiol. Apr 26, 2021; 13(4): 82-94
Published online Apr 26, 2021. doi: 10.4330/wjc.v13.i4.82
Published online Apr 26, 2021. doi: 10.4330/wjc.v13.i4.82
Figure 2 Risk of bias assessment of included studies using risk of bias in non-randomized studies-of interventions tool.
- Citation: Li WJ, Archontakis-Barakakis P, Palaiodimos L, Kalaitzoglou D, Tzelves L, Manolopoulos A, Wang YC, Giannopoulos S, Faillace R, Kokkinidis DG. Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis. World J Cardiol 2021; 13(4): 82-94
- URL: https://www.wjgnet.com/1949-8462/full/v13/i4/82.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i4.82